PR Newswire 2017.05.22 Seoul, Korea, 2017/05/22 – Seegene Inc. (096530.KQ), the world’s leading developer of multiplex molecular diagnostics technologies and assays, today announced that it has entered into a new strategic collaboration relationship with Thermo Fisher Scientific in which Seegene will file for U.S Food and Drug Administration (FDA) clearance of its AllplexTM diagnostic assay... Read more
The DMi8 S with LASX Navigator allows researchers to quickly create high resolution overviews like the whole mouse brain in this example. This facilitates orientation on the sample and easy discovery of critical regions for further examination. Image courtesy of Dr. Wei Mo, School of Life Sciences, Xiamen University, China. “Live-cell imaging is the future... Read more
Basel, 23 May 2017 FDA approves Roche’s Actemra/RoActemra (tocilizumab) for giant cell arteritis Actemra/RoActemra is the first FDA-approved treatment for adults with giant cell arteritis (GCA) FDA previously granted Priority Review and Breakthrough Therapy Designation for Actemra/RoActemra in GCA Sixth FDA approval for Actemra/RoActemra since its US launch in 2010 Roche (SIX: RO, ROG; OTCQX:... Read more
Download PDF Read more
FRANKLIN LAKES, N.J., May 15, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences: Bank of America Merrill Lynch 2017 Healthcare Conference May 17, 2017 11:40 a.m. EDT Jefferies 2017 Global Healthcare Conference June 8, 2017 9:00 a.m.... Read more
Approved for Use in Europe to Identify Head and Neck Cancer Patients Most Likely to Benefit from Opdivo (nivolumab) Therapy SANTA CLARA, Calif., May 15, 2017 Agilent Technologies Inc. (NYSE: A) today announced the expanded use of Agilent’s Dako PD-L1 IHC 28-8 pharmDx test for squamous cell carcinoma of the head and neck (SCCHN), the... Read more
Chatsworth, California, May 15, 2017 – Hitachi High Technologies America, Inc. (HTA), an American subsidiary of Hitachi High-Technologies Corporation (TOKYO: 8036, Hitachi High-Tech), announces that it will open “Hitachi High Tech Science Park” in Chatsworth, California, on June 9, 2017, to work more closely with Hitachi High-Tech’s Scientific Systems Business (including, for example, electron microscopes)... Read more
Basel, 11 May 2017 Roche to present new data on personalised medicines and cancer immunotherapies at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting 20 Roche medicines are included in more than 190 abstracts during ASCO 2017 New pivotal results for Perjeta (pertuzumab) and Alecensa (alectinib) improve upon standards of care Early... Read more
WASHINGTON, May 10, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada on Wednesday, May 17, 2017 at 9:20 a.m. PT. The audio will be simultaneously webcast on www.danaher.com. ... Read more
As part of Egypt’s vision to improve the quality and availability of healthcare in country, the government set forth an ambitious development plan that aims to avail and improve public healthcare services in each governate across Egypt. Under this plan, GE Healthcare signed a key deal in Berlin, worth 25.8 million USD, to supply more... Read more